Dr. Reddy’s announces the launch of Ertapenem for Injection in the U.S. market
HYDERBAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratoriesannounced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) for injection, 1 g/vial approved by the U.S. Food and Drug Administration (USFDA). “We are pleased to bring this important product to market at this time,” says Marc